11:08 AM EST, 11/27/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.32% to 1,320.28 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and accommodation booking company trivago (TRVG), which rose 8% and 5.1% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and biotech firm BioNTech (BNTX), which increased 1.9% and 0.8% respectively.

The decliners from continental Europe were led by biopharmaceutical company Grifols ( GRFS ) and biotech firm Evaxion Biotech ( EVAX ) , which lost 9% and 1.9% respectively. They were followed by medical device EDAP TMS ( EDAP ) and biopharmaceutical company Cellectis ( CLLS ) , which fell 1.6% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which advanced 6.6% and 4% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Biodexa Pharmaceuticals ( BDRX ) , which were up 3.1% and 1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and TC Biopharm ( TCBP ) , which dropped 0.9% and 0.2% respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and Bicycle Therapeutics ( BCYC ) , which were off 2.7% and 0.6% respectively.